搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Too Old to Operate
5 天
Patency Rates After OSR and FB-EVAR for Target Artery Reconstruction
The following is a summary of “Target Artery Outcomes Following Endovascular versus Open Surgical Repair of Thoracoabdominal ...
11 天
Humacyte Clinical Results Highlighting Benefit of the ATEV™ in the Repair of Civilian and ...
In two studies the acellular tissue engineered vessel (ATEV) provided benefits in terms of patency, limb salvage, and infection resistance ...
Yahoo Finance
7 天
Merit Medical’s WRAPSODY WAVE Trial Exceeds Performance Goals for Arteriovenous Graft ...
However, over time, the graft may become narrow or blocked, resulting in potentially life-threatening consequences. Merit’s WRAPSODY Cell-Impermeable Endoprosthesis is designed to restore and extend ...
Endovascular Today
7 天
Merit’s Wrapsody Device Evaluated in WAVE Pivotal Trial’s Arteriovenous Graft Cohort
Merit Medical Systems, Inc. announced 6-month findings from the single-arm arteriovenous graft (AVG) cohort of the WAVE pivota ...
10 天
Humacyte sees success in dual emergency-engineered tissue trials
The two studies of the company’s engineered vascular tissue saw success with casualties in Ukraine and the US.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈